Glifo 10 mg (Tablet)

Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)

Strip Price: ৳ 250.00

Medicine Details

Category	Details
Generic	Empagliflozin
Company	Acme laboratories ltd
Also available as	Glifo 25 mg tablet

Indications

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease

Pharmacology

Sodium glucose co-transporter-2 (SGLT-2) inhibitor

Dosage & Administration

Recommended dose of 10 mg once daily
Can be taken in the morning, with or without food
Dose may be increased to 25 mg once daily in patients tolerating Empagliflozin
Correct volume depletion prior to initiation

Interaction

Co-administration with diuretics resulted in increased urine volume
Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia
Monitoring glycemic control with urine glucose tests is not recommended
Monitoring glycemic control with 1,5-anhydroglucitol (1,5-AG) assay is not recommended

Contraindications

History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
Severe renal impairment
End-stage renal disease
Dialysis

Side Effects

Urinary tract infections
Female genital mycotic infections
Dehydration
Hypotension
Weakness
Dizziness
Increased thirstiness

Pregnancy & Lactation

No adequate and well-controlled studies in pregnant women
Use during pregnancy only if potential benefit justifies potential risk to the fetus
Not recommended when breastfeeding

Precautions & Warnings

Assessment of renal function prior to initiation and periodically thereafter
Not initiated in patients with eGFR less than 45 ml/min/1.73 m^2
No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m^2

Overdose Effects

Supportive measures should be employed

Therapeutic Class

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children

Chemical Structure

Molecular Formula: C23H27ClO7

Common Questions about Glifo 10 mg Tablet

Used to improve glycemic control in adults
May be unsafe to use during pregnancy
Probably unsafe to use during breastfeeding
Should be used cautiously in patients with underlying kidney disease
No dose adjustment needed for patients with mild to moderate liver disease

Quick Tips

Used alone or together with other diabetes medicines to control blood sugar and avoid long-term complications
May cause dehydration, increased thirstiness, and hypotension
May cause hypoglycemia when used with other antidiabetic medicines or alcohol
Can cause genital fungal and/or urinary tract infections in both females and males
Monitor blood sugar regularly while taking Glifo 10 mg Tablet